# Nalbuphine for the Treatment of Opioid Induced Pruritus in Children

> **NCT00323154** · PHASE3 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 134 (estimated)

## Conditions studied

- Pruritis

## Interventions

- **DRUG:** Nalbuphine

## Key facts

- **NCT ID:** NCT00323154
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2008-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00323154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00323154, "Nalbuphine for the Treatment of Opioid Induced Pruritus in Children". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00323154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*